199 related articles for article (PubMed ID: 11135068)
1. No complement receptor 1 stumps on podocytes in human glomerulopathies.
Moll S; Miot S; Sadallah S; Gudat F; Mihatsch MJ; Schifferli JA
Kidney Int; 2001 Jan; 59(1):160-8. PubMed ID: 11135068
[TBL] [Abstract][Full Text] [Related]
2. [Expression of neonatal Fc receptor on human nephritis and rat nephritis models].
Feng ST; Gan HL; Sun JY; Jiang T; Liu BL; Zhao ZH; Guo MY; Zhang ZG
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):81-5. PubMed ID: 22455882
[TBL] [Abstract][Full Text] [Related]
3. Characterizing Glomerular Barrier Dysfunction with Patient-Derived Serum in Glomerulus-on-a-Chip Models: Unveiling New Insights into Glomerulonephritis.
Kim SY; Choi YY; Kwon EJ; Seo S; Kim WY; Park SH; Park S; Chin HJ; Na KY; Kim S
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791159
[TBL] [Abstract][Full Text] [Related]
4. Expression of nephrin in acquired human glomerular disease.
Huh W; Kim DJ; Kim MK; Kim YG; Oh HY; Ruotsalainen V; Tryggvason K
Nephrol Dial Transplant; 2002 Mar; 17(3):478-84. PubMed ID: 11865096
[TBL] [Abstract][Full Text] [Related]
5. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
6. CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patients.
Teixeira JE; Costa RS; Lachmann PJ; Würzner R; Barbosa JE
Clin Exp Immunol; 1996 Sep; 105(3):497-503. PubMed ID: 8809140
[TBL] [Abstract][Full Text] [Related]
7. Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. An immunofluorescence study.
Tamai H; Matsuo S; Fukatsu A; Nishikawa K; Sakamoto N; Yoshioka K; Okada N; Okada H
Clin Exp Immunol; 1991 May; 84(2):256-62. PubMed ID: 1709070
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
Fischer E; Appay MD; Cook J; Kazatchkine MD
J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
[TBL] [Abstract][Full Text] [Related]
9. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies.
Hill GS; Karoui KE; Karras A; Mandet C; Van Huyen JD; Nochy D; Bruneval P
Kidney Int; 2011 Mar; 79(6):635-642. PubMed ID: 21160460
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to human complement receptor (CR1) detect defects in glomerular diseases.
Emancipator SN; Iida K; Nussenzweig V; Gallo GR
Clin Immunol Immunopathol; 1983 May; 27(2):170-5. PubMed ID: 6223755
[TBL] [Abstract][Full Text] [Related]
11. Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes.
Pascual M; Steiger G; Sadallah S; Paccaud JP; Carpentier JL; James R; Schifferli JA
J Exp Med; 1994 Mar; 179(3):889-99. PubMed ID: 8113681
[TBL] [Abstract][Full Text] [Related]
12. Expression of types I, II, and III TGF-beta receptors in human glomerulonephritis.
Yamamoto T; Watanabe T; Ikegaya N; Fujigaki Y; Matsui K; Masaoka H; Nagase M; Hishida A
J Am Soc Nephrol; 1998 Dec; 9(12):2253-61. PubMed ID: 9848779
[TBL] [Abstract][Full Text] [Related]
13. Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis.
Xu C; Miao Y; Pi Q; Zhu S; Li F
Clin Immunol; 2018 Dec; 197():179-185. PubMed ID: 30296590
[TBL] [Abstract][Full Text] [Related]
14. Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides.
Niemir ZI; Stein H; Dworacki G; Mundel P; Koehl N; Koch B; Autschbach F; Andrassy K; Ritz E; Waldherr R; Otto HF
Kidney Int; 1997 Aug; 52(2):393-403. PubMed ID: 9263995
[TBL] [Abstract][Full Text] [Related]
15. Enhanced presence of thrombomodulin in the glomeruli of lupus glomerulonephritis.
Tomura S; Deguchi F; Marumo F; Aoki N
Clin Nephrol; 1994 Apr; 41(4):205-10. PubMed ID: 8026112
[TBL] [Abstract][Full Text] [Related]
16. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.
Mizdrak M; Vukojević K; Filipović N; Čapkun V; Benzon B; Durdov MG
Diagn Pathol; 2018 Nov; 13(1):90. PubMed ID: 30458823
[TBL] [Abstract][Full Text] [Related]
17. [The involvement of neprilysin in the pathogenesis of glomerulopathies].
Kubiak-Wlekły A; Niemir ZI
Pol Merkur Lekarski; 2009 Sep; 27(159):239-41. PubMed ID: 19827739
[TBL] [Abstract][Full Text] [Related]
18. Coexistent findings of renal glomerular disease with Hashimoto's thyroiditis.
Koçak G; Huddam B; Azak A; Ortabozkoyun L; Duranay M
Clin Endocrinol (Oxf); 2012 May; 76(5):759-62. PubMed ID: 22106873
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.
Kazatchkine MD; Fearon DT; Appay MD; Mandet C; Bariety J
J Clin Invest; 1982 Apr; 69(4):900-12. PubMed ID: 7042757
[TBL] [Abstract][Full Text] [Related]
20. Use of complement receptor 1 (CD35) assay in the diagnosis and prognosis of immune complex mediated glomerulopathies.
Raju KR; Sivasankar B; Anand V; Luthra K; Tiwari SC; Dinda AK; Das N; Srivastava LM
Asian Pac J Allergy Immunol; 2001 Mar; 19(1):23-7. PubMed ID: 11495296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
